UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 134

Sortiert nach

Curing HIV: Seeking to Target and Clear Persistent Infection

Cell, 2020-04, Vol.181 (1), p.189-206

2020

Volltextzugriff (PDF)

Precise Quantitation of the Latent HIV-1 Reservoir: Implications for Eradication Strategies

The Journal of infectious diseases, 2015-11, Vol.212 (9), p.1361-1365

2015

Volltextzugriff (PDF)

Treatment to Prevent Transmission of HIV-1

Clinical infectious diseases, 2010-05, Vol.50 (Supplement-3), p.S85-S95

2010

Volltextzugriff (PDF)

Clinical Trial of the Anti-PD-L1 Antibody BMS-936559 in HIV-1 Infected Participants on Suppressive Antiretroviral Therapy

The Journal of infectious diseases, 2017-06, Vol.215 (11), p.1725-1733

2017

Volltextzugriff (PDF)

The Detection of Acute HIV Infection

The Journal of infectious diseases, 2010-10, Vol.202 (Supplement-2), p.S270-S277

2010

Volltextzugriff (PDF)

Immediate antiviral therapy appears to restrict resting CD4⁺ cell HIV-1 infection without accelerating the decay of latent infection

Proceedings of the National Academy of Sciences - PNAS, 2012-06, Vol.109 (24), p.9523-9528

2012

Volltextzugriff (PDF)

Safety, efficacy, and immunogenicity of the NVX-CoV2373 vaccine

Expert review of vaccines, 2023-12, Vol.22 (1), p.501-517

2023

Volltextzugriff (PDF)

Combined noncanonical NF-κB agonism and targeted BET bromodomain inhibition reverse HIV latency ex vivo

The Journal of clinical investigation, 2022-04, Vol.132 (8), p.1-14

2022

Volltextzugriff (PDF)

The HIV-1 latent reservoir is largely sensitive to circulating T cells

eLife, 2020-10, Vol.9

2020

Volltextzugriff (PDF)

Phylodynamic Analysis Complements Partner Services by Identifying Acute and Unreported HIV Transmission

Viruses, 2020-01, Vol.12 (2), p.145

2020

Volltextzugriff (PDF)

Ongoing HIV Transmission and the HIV Care Continuum in North Carolina

PloS one, 2015-06, Vol.10 (6), p.e0127950-e0127950

2015

Volltextzugriff (PDF)

Interval dosing with the HDAC inhibitor vorinostat effectively reverses HIV latency

The Journal of clinical investigation, 2017-08, Vol.127 (8), p.3126-3135

2017

Volltextzugriff (PDF)

HIV-Specific T Cell Responses Are Highly Stable on Antiretroviral Therapy

Molecular therapy. Methods & clinical development, 2019-12, Vol.15, p.9-17

2019

Volltextzugriff (PDF)

Vorinostat Renders the Replication-Competent Latent Reservoir of Human Immunodeficiency Virus (HIV) Vulnerable to Clearance by CD8 T Cells

EBioMedicine, 2017-09, Vol.23 (C), p.52-58

2017

Volltextzugriff (PDF)

The Gap between Human Immunodeficiency Virus (HIV) Infection and Advances in HIV Treatment

Clinical infectious diseases, 2010-06, Vol.50 (11), p.1521-1523

Gay, Cynthia L.

2010

Volltextzugriff (PDF)

Longitudinal Dynamics of Intact HIV Proviral DNA and Outgrowth Virus Frequencies in a Cohort of Individuals Receiving Antiretroviral Therapy

The Journal of infectious diseases, 2021-07, Vol.224 (1), p.92-100

2021

Volltextzugriff (PDF)

Dual-Affinity Re-Targeting proteins direct T cell-mediated cytolysis of latently HIV-infected cells

The Journal of clinical investigation, 2015-11, Vol.125 (11), p.4077-4090

2015

Volltextzugriff (PDF)

Stable Latent HIV Infection and Low-level Viremia Despite Treatment With the Broadly Neutralizing Antibody VRC07-523LS and the Latency Reversal Agent Vorinostat

The Journal of infectious diseases, 2022-03, Vol.225 (5), p.856-861

2022

Volltextzugriff (PDF)

T cells establish and maintain CNS viral infection in HIV-infected humanized mice

The Journal of clinical investigation, 2018-07, Vol.128 (7), p.2862-2876

2018

Volltextzugriff (PDF)

Expanding community engagement in HIV clinical trials: a pilot study using crowdsourcing

AIDS (London), 2020-07, Vol.34 (8), p.1195-1204

2020

Volltextzugriff (PDF)

A Novel Algorithm to Improve PrEP Adherence Monitoring Using Dried Blood Spots

Clinical pharmacology and therapeutics, 2023-04, Vol.113 (4), p.896-903

2023

Volltextzugriff (PDF)

1 – 25 von 134

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(130)
Mit Volltextzugriff
(120)

Publikationsform

Sprache

Englisch
(134)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Curing HIV: Seeking to Target and Clear Persistent Infection

Precise Quantitation of the Latent HIV-1 Reservoir: Implications for Eradication Strategies

Treatment to Prevent Transmission of HIV-1

Clinical Trial of the Anti-PD-L1 Antibody BMS-936559 in HIV-1 Infected Participants on Suppressive Antiretroviral Therapy

The Detection of Acute HIV Infection

Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial

Immediate antiviral therapy appears to restrict resting CD4⁺ cell HIV-1 infection without accelerating the decay of latent infection

Safety, efficacy, and immunogenicity of the NVX-CoV2373 vaccine

Combined noncanonical NF-κB agonism and targeted BET bromodomain inhibition reverse HIV latency ex vivo

Safety and pharmacokinetics of VRC07-523LS administered via different routes and doses (HVTN 127/HPTN 087): A Phase I randomized clinical trial

The HIV-1 latent reservoir is largely sensitive to circulating T cells

Publisher Correction: Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial

Phylodynamic Analysis Complements Partner Services by Identifying Acute and Unreported HIV Transmission

Ongoing HIV Transmission and the HIV Care Continuum in North Carolina

Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico

Interval dosing with the HDAC inhibitor vorinostat effectively reverses HIV latency

HIV-Specific T Cell Responses Are Highly Stable on Antiretroviral Therapy

Vorinostat Renders the Replication-Competent Latent Reservoir of Human Immunodeficiency Virus (HIV) Vulnerable to Clearance by CD8 T Cells

The Gap between Human Immunodeficiency Virus (HIV) Infection and Advances in HIV Treatment

Longitudinal Dynamics of Intact HIV Proviral DNA and Outgrowth Virus Frequencies in a Cohort of Individuals Receiving Antiretroviral Therapy

Dual-Affinity Re-Targeting proteins direct T cell-mediated cytolysis of latently HIV-infected cells

Stable Latent HIV Infection and Low-level Viremia Despite Treatment With the Broadly Neutralizing Antibody VRC07-523LS and the Latency Reversal Agent Vorinostat

T cells establish and maintain CNS viral infection in HIV-infected humanized mice

Expanding community engagement in HIV clinical trials: a pilot study using crowdsourcing

A Novel Algorithm to Improve PrEP Adherence Monitoring Using Dried Blood Spots

Suchergebnisse filtern